Your browser doesn't support javascript.
loading
Long COVID Clinical Phenotypes up to 6 Months After Infection Identified by Latent Class Analysis of Self-Reported Symptoms.
Gottlieb, Michael; Spatz, Erica S; Yu, Huihui; Wisk, Lauren E; Elmore, Joann G; Gentile, Nicole L; Hill, Mandy; Huebinger, Ryan M; Idris, Ahamed H; Kean, Efrat R; Koo, Katherine; Li, Shu-Xia; McDonald, Samuel; Montoy, Juan Carlos C; Nichol, Graham; O'Laughlin, Kelli N; Plumb, Ian D; Rising, Kristin L; Santangelo, Michelle; Saydah, Sharon; Wang, Ralph C; Venkatesh, Arjun; Stephens, Kari A; Weinstein, Robert A.
Affiliation
  • Gottlieb M; Department of Emergency Medicine, Rush University Medical Center, Chicago, Illinois, USA.
  • Spatz ES; Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
  • Yu H; Department of Epidemiology, Yale School of Public Health, New Haven, Connecticut, USA.
  • Wisk LE; Yale Center for Outcomes Research and Evaluation, Yale School of Medicine, New Haven, Connecticut, USA.
  • Elmore JG; Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
  • Gentile NL; Yale Center for Outcomes Research and Evaluation, Yale School of Medicine, New Haven, Connecticut, USA.
  • Hill M; Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA.
  • Huebinger RM; Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA.
  • Idris AH; Post-COVID Rehabilitation and Recovery Clinic, Department of Family Medicine, Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.
  • Kean ER; Department of Emergency Medicine, UTHealth, Houston, Texas, USA.
  • Koo K; Department of Emergency Medicine, UTHealth, Houston, Texas, USA.
  • Li SX; Department of Emergency Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • McDonald S; Department of Emergency Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
  • Montoy JCC; Department of Internal Medicine, Rush University Medical Center, Chicago, Illinois, USA.
  • Nichol G; Yale Center for Outcomes Research and Evaluation, Yale School of Medicine, New Haven, Connecticut, USA.
  • O'Laughlin KN; Department of Emergency Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Plumb ID; Clinical Informatics Center, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Rising KL; Department of Emergency Medicine, University of California, San Francisco, San Francisco, California, USA.
  • Santangelo M; Departments of Medicine and Emergency Medicine, University of Washington, Seattle, Washington, USA.
  • Saydah S; Departments of Emergency Medicine and Global Health, University of Washington, Seattle, Washington, USA.
  • Wang RC; National Center for Immunizations and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Venkatesh A; Department of Emergency Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
  • Stephens KA; Center for Connected Care, Sidney Kimmel Medical School, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
  • Weinstein RA; Department of Internal Medicine, Rush University Medical Center, Chicago, Illinois, USA.
Open Forum Infect Dis ; 10(7): ofad277, 2023 Jul.
Article in En | MEDLINE | ID: mdl-37426952
ABSTRACT

Background:

The prevalence, incidence, and interrelationships of persistent symptoms after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection vary. There are limited data on specific phenotypes of persistent symptoms. Using latent class analysis (LCA) modeling, we sought to identify whether specific phenotypes of COVID-19 were present 3 months and 6 months post-infection.

Methods:

This was a multicenter study of symptomatic adults tested for SARS-CoV-2 with prospectively collected data on general symptoms and fatigue-related symptoms up to 6 months postdiagnosis. Using LCA, we identified symptomatically homogenous groups among COVID-positive and COVID-negative participants at each time period for both general and fatigue-related symptoms.

Results:

Among 5963 baseline participants (4504 COVID-positive and 1459 COVID-negative), 4056 had 3-month and 2856 had 6-month data at the time of analysis. We identified 4 distinct phenotypes of post-COVID conditions (PCCs) at 3 and 6 months for both general and fatigue-related symptoms; minimal-symptom groups represented 70% of participants at 3 and 6 months. When compared with the COVID-negative cohort, COVID-positive participants had higher occurrence of loss of taste/smell and cognition problems. There was substantial class-switching over time; those in 1 symptom class at 3 months were equally likely to remain or enter a new phenotype at 6 months.

Conclusions:

We identified distinct classes of PCC phenotypes for general and fatigue-related symptoms. Most participants had minimal or no symptoms at 3 and 6 months of follow-up. Significant proportions of participants changed symptom groups over time, suggesting that symptoms present during the acute illness may differ from prolonged symptoms and that PCCs may have a more dynamic nature than previously recognized. Clinical Trials Registration. NCT04610515.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Diagnostic_studies / Risk_factors_studies Language: En Journal: Open Forum Infect Dis Year: 2023 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Diagnostic_studies / Risk_factors_studies Language: En Journal: Open Forum Infect Dis Year: 2023 Document type: Article Affiliation country: United States